OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy
Jialiang Zheng, Fenglin Miao, Zhao Wang, et al.
Life Sciences (2023) Vol. 327, pp. 121832-121832
Closed Access | Times Cited: 5
Jialiang Zheng, Fenglin Miao, Zhao Wang, et al.
Life Sciences (2023) Vol. 327, pp. 121832-121832
Closed Access | Times Cited: 5
Showing 5 citing articles:
Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses
Benlin Wang, Yifeng Qiu, Ming Xie, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Benlin Wang, Yifeng Qiu, Ming Xie, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy
Zhibin Wang, Xiu Zhang, Chao Fang, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
Zhibin Wang, Xiu Zhang, Chao Fang, et al.
Immunology (2024) Vol. 173, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways
Wei Wang, Mariela C Aguilar, Sayantap Datta, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wei Wang, Mariela C Aguilar, Sayantap Datta, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Discovery of ganoderic acid A (GAA) PROTACs as MDM2 protein degraders for the treatment of breast cancer
Yan Li, Guangyu Li, Chenwei Zuo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116367-116367
Closed Access | Times Cited: 3
Yan Li, Guangyu Li, Chenwei Zuo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116367-116367
Closed Access | Times Cited: 3
